Transgene Biotek Ltd (TBL) is engaged in manufacturing drugs for:New Drug Delivery System (NDDS)-Oral Delivery of Insulin,Oral Delivery Hepatitis B Vaccine and Pegylation of Protein Drugs for Sustained Release.Biogeneries-Tacrolimus and Pegylated EPO.Human Vaccines-Meningococcal Meningitis,Universal Meningococcal Meningitis,Haemophilus Influenza B-Hib,DTP+Hib+Hep B Combination,etc.Cancer Drugs/Oncology-Multiple Myeloma,Barrett's Esophageal Cancer,Colon Cancer and Breast Cancer..The company also in the business segment of Diagnostics, CRO Services.

Read more